Arkolith/Insider Trading/DCPH/Form 4

Friedman Franklin Stuart

DirectorDeciphera Pharmaceuticals, Inc. (DCPH) · full profile →Form 4 · filed Jun 12, 2023
Net Buying
Open-Market Buys
$139K
Open-Market Sells
$0
Net Open-Market Flow
$139K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 8, 2023Buy(P)10K$13.88$139K10K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-036244) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML